[HTML][HTML] Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods
One of the objectives of the Adolescent Brain Cognitive Development (ABCD) Study
(https://abcdstudy. org/) is to establish a national longitudinal cohort of 9 and 10 year olds …
(https://abcdstudy. org/) is to establish a national longitudinal cohort of 9 and 10 year olds …
Does inhibitory control training improve health behaviour? A meta-analysis
Objectives: Inhibitory control training has been hypothesised as a technique that will
improve an individual's ability to overrule impulsive reactions in order to regulate behaviour …
improve an individual's ability to overrule impulsive reactions in order to regulate behaviour …
Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized …
MP Bogenschutz, S Ross, S Bhatt, T Baron… - JAMA …, 2022 - jamanetwork.com
Importance Although classic psychedelic medications have shown promise in the treatment
of alcohol use disorder (AUD), the efficacy of psilocybin remains unknown. Objective To …
of alcohol use disorder (AUD), the efficacy of psilocybin remains unknown. Objective To …
Alcohol consumption in response to the COVID-19 pandemic in the United States
Objectives: Excessive alcohol use is a serious and growing public health problem. Alcoholic
beverage sales in the United States increased greatly immediately after the stay-at-home …
beverage sales in the United States increased greatly immediately after the stay-at-home …
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu… - The American journal of …, 2017 - Taylor & Francis
Background: A recent open-label pilot study (N= 15) found that two to three moderate to high
doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination …
doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination …
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Background A substantial and unmet clinical need exists for pharmacological treatment of
cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which …
cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which …
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study
MP Bogenschutz, AA Forcehimes… - Journal of …, 2015 - journals.sagepub.com
Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically
relevant effects in alcohol and drug addiction. Although recent studies have investigated the …
relevant effects in alcohol and drug addiction. Although recent studies have investigated the …
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu… - Journal of …, 2014 - journals.sagepub.com
Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of
substance use disorders, rigorous follow-up has not been conducted. To determine the …
substance use disorders, rigorous follow-up has not been conducted. To determine the …
LGB-affirmative cognitive-behavioral therapy for young adult gay and bisexual men: A randomized controlled trial of a transdiagnostic minority stress approach.
JE Pachankis, ML Hatzenbuehler… - Journal of consulting …, 2015 - psycnet.apa.org
Objectives: We tested the preliminary efficacy of a transdiagnostic cognitive-behavioral
treatment adapted to improve depression, anxiety, and co-occurring health risks (ie, alcohol …
treatment adapted to improve depression, anxiety, and co-occurring health risks (ie, alcohol …
[HTML][HTML] A mind-brain-body dataset of MRI, EEG, cognition, emotion, and peripheral physiology in young and old adults
A Babayan, M Erbey, D Kumral, JD Reinelt, AMF Reiter… - Scientific data, 2019 - nature.com
We present a publicly available dataset of 227 healthy participants comprising a young (N=
153, 25.1±3.1 years, range 20–35 years, 45 female) and an elderly group (N= 74, 67.6±4.7 …
153, 25.1±3.1 years, range 20–35 years, 45 female) and an elderly group (N= 74, 67.6±4.7 …